LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Barinthus Biotherapeutics plc

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERBRNS
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / BRNS COVERAGE

What’s moving Barinthus Biotherapeutics plc now

Current reporting with the operating signal separated from the noise.

01
BRNS

Barinthus Biotherapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc

The story matters when it changes Barinthus Biotherapeutics plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?

Investors are testing whether Barinthus Biotherapeutics plc’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Depositary Receipt (BRNS) Price Target Increased by 10.00% to 5.61

Barinthus Biotherapeutics plc

The story matters when it changes Barinthus Biotherapeutics plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Barinthus Biotherapeutics PLC ADR

Barinthus Biotherapeutics PLC ADR

The story matters when it changes Barinthus Biotherapeutics plc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest BRNS filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-04-30 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-07 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-13 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-02 · Period 2026-06-30SEC ↗8-KMaterial company eventFiled 2026-05-21 · Period 2026-05-20SEC ↗8-KMaterial company eventFiled 2026-04-30 · Period 2026-04-30SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-06-10 · Period 2026-07-02SEC ↗ARSOfficial SEC filingFiled 2026-06-10 · Period 2025-12-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Barinthus Biotherapeutics plc, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.